nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—NISCH—Podofilox—Etoposide—testicular cancer	0.0131	0.539	CbGdCrCtD
Tizanidine—NISCH—Vincristine—Vinblastine—testicular cancer	0.0112	0.461	CbGdCrCtD
Tizanidine—Diarrhoea—Ifosfamide—testicular cancer	0.000666	0.000682	CcSEcCtD
Tizanidine—Renal failure—Epirubicin—testicular cancer	0.000664	0.000681	CcSEcCtD
Tizanidine—Body temperature increased—Cisplatin—testicular cancer	0.000663	0.00068	CcSEcCtD
Tizanidine—Fatigue—Etoposide—testicular cancer	0.000663	0.000679	CcSEcCtD
Tizanidine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000662	0.000679	CcSEcCtD
Tizanidine—Jaundice—Epirubicin—testicular cancer	0.000658	0.000675	CcSEcCtD
Tizanidine—Constipation—Etoposide—testicular cancer	0.000657	0.000674	CcSEcCtD
Tizanidine—Conjunctivitis—Epirubicin—testicular cancer	0.000657	0.000673	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—testicular cancer	0.000651	0.000667	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—testicular cancer	0.000648	0.000664	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—testicular cancer	0.000648	0.000664	CcSEcCtD
Tizanidine—Sweating—Epirubicin—testicular cancer	0.000648	0.000664	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—testicular cancer	0.000647	0.000664	CcSEcCtD
Tizanidine—Haematuria—Epirubicin—testicular cancer	0.000644	0.00066	CcSEcCtD
Tizanidine—Dizziness—Ifosfamide—testicular cancer	0.000643	0.00066	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—testicular cancer	0.000643	0.000659	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—testicular cancer	0.00064	0.000656	CcSEcCtD
Tizanidine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000639	0.000655	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—testicular cancer	0.000635	0.000651	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—testicular cancer	0.000634	0.00065	CcSEcCtD
Tizanidine—Sinusitis—Epirubicin—testicular cancer	0.000634	0.00065	CcSEcCtD
Tizanidine—Feeling abnormal—Etoposide—testicular cancer	0.000633	0.000649	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000632	0.000648	CcSEcCtD
Tizanidine—Nausea—Dactinomycin—testicular cancer	0.000631	0.000646	CcSEcCtD
Tizanidine—Agranulocytosis—Epirubicin—testicular cancer	0.00063	0.000646	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—testicular cancer	0.000629	0.000644	CcSEcCtD
Tizanidine—Gastrointestinal pain—Etoposide—testicular cancer	0.000628	0.000644	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—testicular cancer	0.000625	0.000641	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00062	0.000635	CcSEcCtD
Tizanidine—Vomiting—Ifosfamide—testicular cancer	0.000619	0.000634	CcSEcCtD
Tizanidine—Hypersensitivity—Cisplatin—testicular cancer	0.000618	0.000633	CcSEcCtD
Tizanidine—Bradycardia—Epirubicin—testicular cancer	0.000617	0.000633	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—testicular cancer	0.000614	0.00063	CcSEcCtD
Tizanidine—Rash—Ifosfamide—testicular cancer	0.000614	0.000629	CcSEcCtD
Tizanidine—Dermatitis—Ifosfamide—testicular cancer	0.000613	0.000628	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—testicular cancer	0.000613	0.000628	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000613	0.000628	CcSEcCtD
Tizanidine—Urticaria—Etoposide—testicular cancer	0.000611	0.000626	CcSEcCtD
Tizanidine—Haemoglobin—Epirubicin—testicular cancer	0.000609	0.000625	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—testicular cancer	0.000609	0.000624	CcSEcCtD
Tizanidine—Rhinitis—Epirubicin—testicular cancer	0.000608	0.000623	CcSEcCtD
Tizanidine—Abdominal pain—Etoposide—testicular cancer	0.000608	0.000623	CcSEcCtD
Tizanidine—Body temperature increased—Etoposide—testicular cancer	0.000608	0.000623	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—testicular cancer	0.000607	0.000623	CcSEcCtD
Tizanidine—Haemorrhage—Epirubicin—testicular cancer	0.000606	0.000621	CcSEcCtD
Tizanidine—Hepatitis—Epirubicin—testicular cancer	0.000606	0.000621	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—testicular cancer	0.000604	0.000619	CcSEcCtD
Tizanidine—Asthenia—Cisplatin—testicular cancer	0.000602	0.000617	CcSEcCtD
Tizanidine—Pharyngitis—Epirubicin—testicular cancer	0.000602	0.000617	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—testicular cancer	0.000601	0.000616	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—testicular cancer	0.000599	0.000614	CcSEcCtD
Tizanidine—Urinary tract disorder—Epirubicin—testicular cancer	0.000599	0.000614	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—testicular cancer	0.000596	0.000611	CcSEcCtD
Tizanidine—Connective tissue disorder—Epirubicin—testicular cancer	0.000596	0.000611	CcSEcCtD
Tizanidine—Urethral disorder—Epirubicin—testicular cancer	0.000594	0.000609	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000591	0.000606	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—testicular cancer	0.000588	0.000603	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—testicular cancer	0.000586	0.000601	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—testicular cancer	0.000585	0.0006	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—testicular cancer	0.000584	0.000599	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—testicular cancer	0.000583	0.000598	CcSEcCtD
Tizanidine—Nausea—Ifosfamide—testicular cancer	0.000578	0.000592	CcSEcCtD
Tizanidine—Diarrhoea—Cisplatin—testicular cancer	0.000574	0.000588	CcSEcCtD
Tizanidine—Erythema multiforme—Epirubicin—testicular cancer	0.000573	0.000588	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—testicular cancer	0.000573	0.000587	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—testicular cancer	0.000571	0.000585	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—testicular cancer	0.000568	0.000582	CcSEcCtD
Tizanidine—Hypersensitivity—Etoposide—testicular cancer	0.000566	0.00058	CcSEcCtD
Tizanidine—Tinnitus—Epirubicin—testicular cancer	0.000565	0.000579	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—testicular cancer	0.000564	0.000578	CcSEcCtD
Tizanidine—Cardiac disorder—Epirubicin—testicular cancer	0.000563	0.000577	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—testicular cancer	0.000562	0.000577	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—testicular cancer	0.000561	0.000575	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—testicular cancer	0.000561	0.000575	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—testicular cancer	0.000557	0.000571	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000554	0.000568	CcSEcCtD
Tizanidine—Asthenia—Etoposide—testicular cancer	0.000551	0.000565	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000551	0.000565	CcSEcCtD
Tizanidine—Angiopathy—Epirubicin—testicular cancer	0.00055	0.000564	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—testicular cancer	0.00055	0.000564	CcSEcCtD
Tizanidine—Immune system disorder—Epirubicin—testicular cancer	0.000548	0.000561	CcSEcCtD
Tizanidine—Mediastinal disorder—Epirubicin—testicular cancer	0.000546	0.00056	CcSEcCtD
Tizanidine—Back pain—Methotrexate—testicular cancer	0.000546	0.000559	CcSEcCtD
Tizanidine—Pruritus—Etoposide—testicular cancer	0.000544	0.000557	CcSEcCtD
Tizanidine—Arrhythmia—Epirubicin—testicular cancer	0.000542	0.000555	CcSEcCtD
Tizanidine—Alopecia—Epirubicin—testicular cancer	0.000536	0.000549	CcSEcCtD
Tizanidine—Vomiting—Cisplatin—testicular cancer	0.000533	0.000547	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—testicular cancer	0.000532	0.000545	CcSEcCtD
Tizanidine—Mental disorder—Epirubicin—testicular cancer	0.000531	0.000544	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—testicular cancer	0.00053	0.000544	CcSEcCtD
Tizanidine—Rash—Cisplatin—testicular cancer	0.000529	0.000542	CcSEcCtD
Tizanidine—Dermatitis—Cisplatin—testicular cancer	0.000528	0.000542	CcSEcCtD
Tizanidine—Diarrhoea—Etoposide—testicular cancer	0.000526	0.000539	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—testicular cancer	0.000523	0.000536	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—testicular cancer	0.000523	0.000536	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—testicular cancer	0.000521	0.000534	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—testicular cancer	0.000521	0.000534	CcSEcCtD
Tizanidine—Flatulence—Epirubicin—testicular cancer	0.00052	0.000533	CcSEcCtD
Tizanidine—Tension—Epirubicin—testicular cancer	0.000518	0.000531	CcSEcCtD
Tizanidine—Nervousness—Epirubicin—testicular cancer	0.000513	0.000525	CcSEcCtD
Tizanidine—Back pain—Epirubicin—testicular cancer	0.000511	0.000523	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—testicular cancer	0.000509	0.000522	CcSEcCtD
Tizanidine—Malaise—Methotrexate—testicular cancer	0.000509	0.000521	CcSEcCtD
Tizanidine—Dizziness—Etoposide—testicular cancer	0.000508	0.000521	CcSEcCtD
Tizanidine—Muscle spasms—Epirubicin—testicular cancer	0.000507	0.00052	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—testicular cancer	0.000507	0.000519	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—testicular cancer	0.000507	0.000519	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000506	0.000518	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—testicular cancer	0.000505	0.000517	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—testicular cancer	0.000501	0.000514	CcSEcCtD
Tizanidine—Nausea—Cisplatin—testicular cancer	0.000498	0.000511	CcSEcCtD
Tizanidine—Vision blurred—Epirubicin—testicular cancer	0.000497	0.00051	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—testicular cancer	0.000496	0.000508	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—testicular cancer	0.000492	0.000504	CcSEcCtD
Tizanidine—Ill-defined disorder—Epirubicin—testicular cancer	0.00049	0.000502	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—testicular cancer	0.000489	0.000501	CcSEcCtD
Tizanidine—Vomiting—Etoposide—testicular cancer	0.000489	0.000501	CcSEcCtD
Tizanidine—Anaemia—Epirubicin—testicular cancer	0.000488	0.0005	CcSEcCtD
Tizanidine—Agitation—Epirubicin—testicular cancer	0.000485	0.000497	CcSEcCtD
Tizanidine—Rash—Etoposide—testicular cancer	0.000485	0.000497	CcSEcCtD
Tizanidine—Dermatitis—Etoposide—testicular cancer	0.000484	0.000496	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—testicular cancer	0.000481	0.000493	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—testicular cancer	0.00048	0.000492	CcSEcCtD
Tizanidine—Tension—Doxorubicin—testicular cancer	0.000479	0.000491	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000477	0.000489	CcSEcCtD
Tizanidine—Malaise—Epirubicin—testicular cancer	0.000476	0.000488	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—testicular cancer	0.000474	0.000486	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—testicular cancer	0.000474	0.000486	CcSEcCtD
Tizanidine—Vertigo—Epirubicin—testicular cancer	0.000474	0.000486	CcSEcCtD
Tizanidine—Syncope—Epirubicin—testicular cancer	0.000473	0.000485	CcSEcCtD
Tizanidine—Leukopenia—Epirubicin—testicular cancer	0.000472	0.000484	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—testicular cancer	0.000472	0.000484	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—testicular cancer	0.00047	0.000481	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—testicular cancer	0.000464	0.000476	CcSEcCtD
Tizanidine—Loss of consciousness—Epirubicin—testicular cancer	0.000464	0.000476	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—testicular cancer	0.00046	0.000472	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—testicular cancer	0.00046	0.000472	CcSEcCtD
Tizanidine—Convulsion—Epirubicin—testicular cancer	0.000457	0.000469	CcSEcCtD
Tizanidine—Infection—Methotrexate—testicular cancer	0.000457	0.000469	CcSEcCtD
Tizanidine—Nausea—Etoposide—testicular cancer	0.000456	0.000468	CcSEcCtD
Tizanidine—Hypertension—Epirubicin—testicular cancer	0.000456	0.000467	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000453	0.000464	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—testicular cancer	0.000451	0.000463	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—testicular cancer	0.000451	0.000463	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000451	0.000462	CcSEcCtD
Tizanidine—Arthralgia—Epirubicin—testicular cancer	0.000449	0.000461	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—testicular cancer	0.000449	0.00046	CcSEcCtD
Tizanidine—Anxiety—Epirubicin—testicular cancer	0.000448	0.000459	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—testicular cancer	0.000447	0.000458	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000446	0.000457	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—testicular cancer	0.000445	0.000456	CcSEcCtD
Tizanidine—Discomfort—Epirubicin—testicular cancer	0.000444	0.000455	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—testicular cancer	0.00044	0.000451	CcSEcCtD
Tizanidine—Dry mouth—Epirubicin—testicular cancer	0.000439	0.00045	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—testicular cancer	0.000439	0.00045	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—testicular cancer	0.000438	0.000449	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—testicular cancer	0.000437	0.000448	CcSEcCtD
Tizanidine—Confusional state—Epirubicin—testicular cancer	0.000434	0.000445	CcSEcCtD
Tizanidine—Anaphylactic shock—Epirubicin—testicular cancer	0.000431	0.000442	CcSEcCtD
Tizanidine—Oedema—Epirubicin—testicular cancer	0.000431	0.000442	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—testicular cancer	0.00043	0.000441	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—testicular cancer	0.000429	0.00044	CcSEcCtD
Tizanidine—Infection—Epirubicin—testicular cancer	0.000428	0.000439	CcSEcCtD
Tizanidine—Shock—Epirubicin—testicular cancer	0.000424	0.000434	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—testicular cancer	0.000423	0.000434	CcSEcCtD
Tizanidine—Nervous system disorder—Epirubicin—testicular cancer	0.000422	0.000433	CcSEcCtD
Tizanidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000422	0.000432	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—testicular cancer	0.000422	0.000432	CcSEcCtD
Tizanidine—Tachycardia—Epirubicin—testicular cancer	0.00042	0.000431	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000419	0.00043	CcSEcCtD
Tizanidine—Skin disorder—Epirubicin—testicular cancer	0.000418	0.000429	CcSEcCtD
Tizanidine—Hyperhidrosis—Epirubicin—testicular cancer	0.000416	0.000427	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—testicular cancer	0.000416	0.000426	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—testicular cancer	0.000414	0.000425	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—testicular cancer	0.000413	0.000424	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000413	0.000423	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—testicular cancer	0.000411	0.000421	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—testicular cancer	0.00041	0.000421	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—testicular cancer	0.000409	0.000419	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—testicular cancer	0.000407	0.000417	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—testicular cancer	0.000405	0.000415	CcSEcCtD
Tizanidine—Hypotension—Epirubicin—testicular cancer	0.000403	0.000413	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—testicular cancer	0.000402	0.000412	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—testicular cancer	0.000399	0.000409	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000399	0.000409	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—testicular cancer	0.000397	0.000407	CcSEcCtD
Tizanidine—Infection—Doxorubicin—testicular cancer	0.000396	0.000406	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000392	0.000402	CcSEcCtD
Tizanidine—Shock—Doxorubicin—testicular cancer	0.000392	0.000402	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—testicular cancer	0.000391	0.000401	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—testicular cancer	0.00039	0.0004	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—testicular cancer	0.000389	0.000399	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—testicular cancer	0.000387	0.000397	CcSEcCtD
Tizanidine—Paraesthesia—Epirubicin—testicular cancer	0.000387	0.000396	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000385	0.000395	CcSEcCtD
Tizanidine—Dyspnoea—Epirubicin—testicular cancer	0.000384	0.000394	CcSEcCtD
Tizanidine—Somnolence—Epirubicin—testicular cancer	0.000383	0.000393	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—testicular cancer	0.000379	0.000389	CcSEcCtD
Tizanidine—Dyspepsia—Epirubicin—testicular cancer	0.000379	0.000389	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000376	0.000386	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—testicular cancer	0.000372	0.000382	CcSEcCtD
Tizanidine—Fatigue—Epirubicin—testicular cancer	0.000371	0.000381	CcSEcCtD
Tizanidine—Constipation—Epirubicin—testicular cancer	0.000368	0.000378	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—testicular cancer	0.000366	0.000375	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—testicular cancer	0.000364	0.000373	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—testicular cancer	0.000364	0.000373	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000363	0.000372	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—testicular cancer	0.000358	0.000367	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—testicular cancer	0.000355	0.000364	CcSEcCtD
Tizanidine—Feeling abnormal—Epirubicin—testicular cancer	0.000355	0.000364	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—testicular cancer	0.000354	0.000363	CcSEcCtD
Tizanidine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000352	0.000361	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—testicular cancer	0.000351	0.00036	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—testicular cancer	0.000344	0.000352	CcSEcCtD
Tizanidine—Urticaria—Epirubicin—testicular cancer	0.000342	0.000351	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—testicular cancer	0.000341	0.000349	CcSEcCtD
Tizanidine—Abdominal pain—Epirubicin—testicular cancer	0.000341	0.000349	CcSEcCtD
Tizanidine—Body temperature increased—Epirubicin—testicular cancer	0.000341	0.000349	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—testicular cancer	0.000339	0.000348	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—testicular cancer	0.00033	0.000339	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000328	0.000337	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000326	0.000334	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—testicular cancer	0.000326	0.000334	CcSEcCtD
Tizanidine—Hypersensitivity—Epirubicin—testicular cancer	0.000317	0.000325	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—testicular cancer	0.000317	0.000325	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—testicular cancer	0.000315	0.000323	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—testicular cancer	0.000315	0.000323	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—testicular cancer	0.000315	0.000323	CcSEcCtD
Tizanidine—Asthenia—Epirubicin—testicular cancer	0.000309	0.000317	CcSEcCtD
Tizanidine—Pruritus—Epirubicin—testicular cancer	0.000305	0.000312	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—testicular cancer	0.000304	0.000312	CcSEcCtD
Tizanidine—Diarrhoea—Epirubicin—testicular cancer	0.000295	0.000302	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—testicular cancer	0.000294	0.000301	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—testicular cancer	0.000293	0.0003	CcSEcCtD
Tizanidine—Rash—Methotrexate—testicular cancer	0.00029	0.000297	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—testicular cancer	0.00029	0.000297	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—testicular cancer	0.000286	0.000293	CcSEcCtD
Tizanidine—Dizziness—Epirubicin—testicular cancer	0.000285	0.000292	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—testicular cancer	0.000282	0.000289	CcSEcCtD
Tizanidine—Vomiting—Epirubicin—testicular cancer	0.000274	0.000281	CcSEcCtD
Tizanidine—Nausea—Methotrexate—testicular cancer	0.000273	0.00028	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—testicular cancer	0.000273	0.00028	CcSEcCtD
Tizanidine—Rash—Epirubicin—testicular cancer	0.000272	0.000278	CcSEcCtD
Tizanidine—Dermatitis—Epirubicin—testicular cancer	0.000271	0.000278	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—testicular cancer	0.000264	0.00027	CcSEcCtD
Tizanidine—Nausea—Epirubicin—testicular cancer	0.000256	0.000262	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—testicular cancer	0.000253	0.00026	CcSEcCtD
Tizanidine—Rash—Doxorubicin—testicular cancer	0.000251	0.000258	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—testicular cancer	0.000251	0.000257	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—testicular cancer	0.000237	0.000243	CcSEcCtD
